Heart Failure (HF) imposes a significant burden across the UK, both for patients and the NHS.
Optimal management of HF could improve patient outcomes and reduce costs for clinical commissioning groups (CCGs).
HF is, however, complex to manage, and despite recent improvements there is evidence of a continuing lack of adherence to guideline recommendations.
Enhance HF™ is a tool that supports GPs in optimising the management of HF due to left-ventricular systolic dysfunction to help deliver more cost effective care for patients in their practice.
You can read the article from the PharmaTimes website, by following this link, or in the Oct/Nov/Dec 2014 edition of the magazine.